RAD52 Variants Predict Platinum Resistance and Prognosis of Cervical Cancer

• Ting-Yan Shi,

  Affiliations Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, National Population and Family Planning Key Laboratory of Contraceptive Drugs and Devices, Shanghai Institute of Planned Parenthood Research, Shanghai, China

  ⨯
• Gong Yang,

  Affiliation Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xiao-Yu Tu,

  Affiliation Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Jing-Min Yang,

  Affiliation State Key Laboratory of Genetic Engineering, The Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China

  ⨯
• Ji Qian,

  Affiliation State Key Laboratory of Genetic Engineering, The Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China

  ⨯
• Xiao-Hua Wu,

  Affiliation Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xiao-Yan Zhou,

  Affiliations Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xi Cheng ,

  * E-mail: cheng_xi1@hotmail.com

  Affiliation Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Qingyi Wei

  Affiliations Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯